From Recalls to Reliability: Tools to Ensure Software Safety in MedTech
Cutting-edge technology empowers developers to proactively detect and mitigate issues before they cause problems, reducing recalls and fostering trust in the industry.
How Covered Entities and Pharma Companies Can Better Collaborate on Drug Discount Programs
Three things drug manufacturers and CEs can do to build trust and enable effective collaboration
When Investment Rhymes with Canada
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
How Regulatory Ambiguity is Impeding Healthcare Innovation
America should be a global leader in healthcare. Instead, we rank last among our peers, and outmoded regulations are holding us back.
The Senate Attacks on Pharma Put the Industry in Jeopardy and Consumers at Risk
Singling out an industry segment won’t solve the underlying problem of healthcare costs.
Protect Personalized, Independent Kidney Care
A pending CMS policy could cause havoc for independent kidney care facilities and patients who need life-sustaining treatments.
Making Access to AI-enabled Medical Devices Equitable for All
If Medicare acts, the potential of AI-enabled technologies to improve healthcare outcomes for patients, regardless of their geographic location or socioeconomic status, will be closer to being fully realized.
The Impact Brands: Empowering Wellness Through Natural and Holistic Solutions
In an era of escalating healthcare costs and a growing preference for natural, holistic approaches to health, The Impact Brands emerges as a collective of diverse brands dedicated to supporting overall wellness through natural means.
Hospice — The Best Way to Alleviate Loneliness for Middle-Stage Dementia Patients
In-home hospice care, which gives them ample opportunities to engage with family and friends in the comfort of their own homes, allows providers to give dementia patients the daily contact they deserve.
Right-to-Repair Laws Could Threaten Healthcare Safety
Healthcare devices must be exempted from general right to repair legislation.
Why Personalized Medicine Should Not Be Too Personalized
One irony of personalized or precision medicine (PM) is that it aims, against the advice of Hippocrates and Osler, to treat the disease, not the patient.
Momentum is Building to Put Medical Cannabis into Mainstream Healthcare
The Drug Enforcement Agency’s decision to reclassify cannabis to a Schedule III drug could mark the first step in a long process to establish a new normal for medical cannabis care.
At ViVE 2024, Panelists Share Prior Authorization Progress and Frustration in Payer Insights Program
At the Payer Insights sessions on Day 1 of ViVE 2024, a panel on prior authorization offered compelling insights from speakers who shared the positive developments in this area after years of mounting frustration. Speakers also shared challenges as they work with providers to figure out how policy developments and technology will work in practice.
To Further Impede the Progression of Heart Disease, We Must Treat Patients With Anti-Inflammatory Drugs in Combination With Statin Therapy
it is paramount that we address both cholesterol risk and inflammation to reduce the risk of a heart attack or stroke.
Insurer “Delay and Deny” Practices Continue to Threaten Patients’ Timely Access to Gastrointestinal Care – It’s Time for Reform
Insurers should immediately end their overreach into medical decision-making and work with medical providers and their patients to ensure timely care for all.
Leaders Must Better Support Military Nurses to Attract More Students to the Armed Services
When you are a military nurse, you’re not just a clinical professional, you are also a soldier. Those roles take sacrifice, resilience, and courage. I urge leaders and policymakers to consider solutions to the crisis, including creating better incentives that will bolster the pipeline of students pursuing careers as military nurses.
Will 2024 be the Year We Address the Real Roots of the Opioid Crisis?
Will 2024 bring any change, or will we witness yet another record- and heart-breaking year of preventable deaths?
An Attack on Patients’ Right to Informed Consent
This case, about the claim that Merck failed to warn patients about the risk of typical femoral fracture, reaches past this suit to potentially change pharmaceutical companies’ relationship with the FDA.